⌘K
Loading ticker…
Pulmonx Corporation Common Stock · Healthcare · Medical Equipment
As of 2026-06-26, Pulmonx Corporation Common Stock (LUNG) has a 3-month relative strength percentile of 41 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.3%, relative volume 10.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
41 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LUNG is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -9.6% / -24.0%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LUNG is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional. Top 3 carry $3M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M |
| IWMiShares Russell 2000 ETF | 0.00% | $1M |
| VXFVanguard Extended Market ETF | 0.00% | $565K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $402K |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $86K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LUNG Jan avg: -8.13% median: -6.09% win: 50% σ: 15.44% n: 4 2022-04-12 → 2026-05-29 | LUNG Feb avg: 10.96% median: 11.33% win: 50% σ: 35.77% n: 4 2022-04-12 → 2026-05-29 | LUNG Mar avg: -10.05% median: -9.40% win: 25% σ: 11.75% n: 4 2022-04-12 → 2026-05-29 | LUNG Apr avg: -9.90% median: -7.66% win: 20% σ: 13.36% n: 5 2022-04-12 → 2026-05-29 | LUNG May avg: -5.49% median: -4.73% win: 40% σ: 23.32% n: 5 2022-04-12 → 2026-05-29 | LUNG Jun avg: -11.65% median: -15.97% win: 25% σ: 14.63% n: 4 2022-04-12 → 2026-05-29 (current) | LUNG Jul avg: 0.65% median: 7.89% win: 75% σ: 20.10% n: 4 2022-04-12 → 2026-05-29 | LUNG Aug avg: -4.65% median: -0.57% win: 50% σ: 15.26% n: 4 2022-04-12 → 2026-05-29 | LUNG Sep avg: -0.64% median: -3.25% win: 25% σ: 9.83% n: 4 2022-04-12 → 2026-05-29 | LUNG Oct avg: -8.97% median: -17.36% win: 25% σ: 21.98% n: 4 2022-04-12 → 2026-05-29 | LUNG Nov avg: -11.68% median: -7.90% win: 50% σ: 33.76% n: 4 2022-04-12 → 2026-05-29 | LUNG Dec avg: 24.67% median: 26.70% win: 100% σ: 16.43% n: 4 2022-04-12 → 2026-05-29 |